Acute HIV infection syndrome mimicking COVID-19 vaccination side effects : a case report
© 2021. The Author(s)..
BACKGROUND: Symptoms of primary HIV infection, including fever, rash, and headache, are nonspecific and are often described as flu-like. COVID-19 vaccination side effects, such as fever, which occur in up to 10% of people following COVID-19 vaccination, can make the diagnosis of acute HIV infection even more challenging.
CASE PRESENTATION: A 26-year-old man presented with fever and headache following COVID-19 vaccination. The symptoms were initially thought to be vaccine side effects. A diagnostic workup was conducted due to persisting fever and headache > 72 h following vaccination, and he was diagnosed with Fiebig stage II acute HIV infection, 3 weeks after having unprotected anal intercourse with another man.
CONCLUSION: Thorough anamnesis is key to estimating the individual risk of primary HIV infection, in patients presenting with flu-like symptoms. Early diagnosis and initiation of antiretroviral therapy is associated with better prognosis and limits transmission of the disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
AIDS research and therapy - 18(2021), 1 vom: 26. Okt., Seite 78 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Triebelhorn, Julian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute HIV infection |
|---|
| Anmerkungen: |
Date Completed 29.10.2021 Date Revised 30.10.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12981-021-00407-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332406830 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332406830 | ||
| 003 | DE-627 | ||
| 005 | 20231225215517.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12981-021-00407-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332406830 | ||
| 035 | |a (NLM)34702284 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Triebelhorn, Julian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acute HIV infection syndrome mimicking COVID-19 vaccination side effects |b a case report |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.10.2021 | ||
| 500 | |a Date Revised 30.10.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a BACKGROUND: Symptoms of primary HIV infection, including fever, rash, and headache, are nonspecific and are often described as flu-like. COVID-19 vaccination side effects, such as fever, which occur in up to 10% of people following COVID-19 vaccination, can make the diagnosis of acute HIV infection even more challenging | ||
| 520 | |a CASE PRESENTATION: A 26-year-old man presented with fever and headache following COVID-19 vaccination. The symptoms were initially thought to be vaccine side effects. A diagnostic workup was conducted due to persisting fever and headache > 72 h following vaccination, and he was diagnosed with Fiebig stage II acute HIV infection, 3 weeks after having unprotected anal intercourse with another man | ||
| 520 | |a CONCLUSION: Thorough anamnesis is key to estimating the individual risk of primary HIV infection, in patients presenting with flu-like symptoms. Early diagnosis and initiation of antiretroviral therapy is associated with better prognosis and limits transmission of the disease | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Acute HIV infection | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Fiebig | |
| 650 | 4 | |a HIV seroconversion illness | |
| 650 | 4 | |a Seroconversion | |
| 650 | 4 | |a Vaccination | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Haschka, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Hesse, Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Erber, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Weidlich, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Marcel |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffmann, Dieter |e verfasserin |4 aut | |
| 700 | 1 | |a Eberle, Josef |e verfasserin |4 aut | |
| 700 | 1 | |a Spinner, Christoph D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS research and therapy |d 2004 |g 18(2021), 1 vom: 26. Okt., Seite 78 |w (DE-627)NLM154648086 |x 1742-6405 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:26 |g month:10 |g pages:78 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12981-021-00407-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 1 |b 26 |c 10 |h 78 | ||